Xalanol

Xalanol Use In Pregnancy & Lactation

latanoprost + timolol

Manufacturer:

Beximco

Distributor:

Medispec
Full Prescribing Info
Use In Pregnancy & Lactation
Pregnancy: Latanoprost: There are no adequate data from the use of latanoprost in pregnant women. Studies in animals have shown reproductive toxicity. The potential risk for humans is unknown.
Timolol: There are no adequate data for the use of timolol in pregnant women. Timolol should not be used during pregnancy unless clearly necessary. To reduce the systemic absorption, see Method of administration under Dosage & Administration.
Epidemiological studies have not revealed malformative effects but show a risk for intra uterine growth retardation when beta-blockers are administered by the oral route. In addition, signs and symptoms of beta-blockade (e.g. bradycardia, hypotension, respiratory distress and hypoglycaemia) have been observed in the neonate when beta-blockers have been administered until delivery. If Xalanol is administered until delivery, the neonate should be carefully monitored during the first days of life. Consequently Xalanol should not be used during pregnancy.
Breast-feeding: Beta-blockers are excreted in breast milk. However, at therapeutic doses of timolol in eye drops it is not likely that sufficient amounts would be present in breast milk to produce clinical symptoms of beta-blockade in the infant. To reduce the systemic absorption, see Method of administration under Dosage & Administration.
Latanoprost and its metabolites may pass into breast milk. Xalanol should therefore not be used in women who are breast-feeding.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in